name:-0.017583131790161
name:-0.0064518451690674
name:-0.00041699409484863
Schmidt; Christopher J. Patent Filings

Schmidt; Christopher J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schmidt; Christopher J..The latest application filed is for "power crimping tool".

Company Profile
0.6.11
  • Schmidt; Christopher J. - Fairless Hills PA
  • Schmidt, Christopher J. - Old Lyme CT
  • Schmidt; Christopher J. - Oregonia OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Power crimping tool
Grant 7,146,837 - Schmidt December 12, 2
2006-12-12
Power crimping tool
App 20050056072 - Schmidt, Christopher J.
2005-03-17
Therapeutic use of selective PDE10 inhibitors
App 20040162294 - Lebel, Lorraine A. ;   et al.
2004-08-19
Therapeutic use of selective PDE10 inhibitors
App 20040162293 - Lebel, Lorraine A. ;   et al.
2004-08-19
Monoamine reuptake inhibitors for treatment of CNS disorders
App 20040048856 - Howard, Harry R. JR. ;   et al.
2004-03-11
Monoamine reuptake inhibitors for treatment of CNS disorders
Grant 6,677,378 - Howard, Jr. , et al. January 13, 2
2004-01-13
Combination treatment for depression and anxiety
App 20040001895 - Sobolov-Jaynes, Susan B. ;   et al.
2004-01-01
Combination treatment for depression and anxiety
App 20030235631 - Sobolov-Jaynes, Susan B. ;   et al.
2003-12-25
Disruption of the phosphodiesterase 10 gene
App 20030121069 - Menniti, Frank S. ;   et al.
2003-06-26
Therapeutic use of selective PDE10 inhibitors
App 20030032579 - Lebel, Lorraine A. ;   et al.
2003-02-13
Therapeutic use of selective PDE10 inhibitors
App 20030018047 - Lebel, Lorraine A. ;   et al.
2003-01-23
Therapeutic use of selective PDE10 inhibitors
App 20030008806 - Lebel, Lorraine A. ;   et al.
2003-01-09
Monoamine reuptake inhibitors for treatment of CNS disorders
App 20020143003 - Howard, Harry R. JR. ;   et al.
2002-10-03
Treatment of obsessive-compulsive disorders with 5-HT.sub.2 antagonists
Grant 5,618,824 - Schmidt , et al. April 8, 1
1997-04-08
(+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
Grant 5,561,144 - Carr , et al. October 1, 1
1996-10-01
Method of treating drug abuse
Grant 5,500,433 - Carr , et al. March 19, 1
1996-03-19
(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[ 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
Grant 5,134,149 - Carr , et al. July 28, 1
1992-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed